EMA’s Medical Literature Monitoring

The European Medicines Agency (EMA) recently launched their new literature-screening service, Medical Literature Monitoring (MLM). Whether it will ultimately lessen the burden on market authorization holders or add unwanted complexity to their workflows remains to be seen, but the MLM is certainly changing the PV landscape.

Read more